Stock HRTIS HERANTIS PHARMA OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Market Closed - Nasdaq Helsinki
Other stock markets
 05:16:37 26/04/2024 pm IST 		5-day change 1st Jan Change
1.46 EUR +2.10% Intraday chart for Herantis Pharma Oyj +1.74% -7.30%
06/03 Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 CI
06/03 Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
Herantis Pharma's Early-stage Study of Parkinson's Therapy Shows Positive Data; Stock Surges
Herantis Pharma Plc Announces Positive Topline Data from Phase 1a Clinical Trial of HER-096
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2023
Herantis Pharma plc Announces First Healthy Volunteers Dosed in the Part 2 of the Her-096 Phase 1A Clinical Study
Herantis Pharma Plc Announces Start of Recruitment of Healthy Volunteers for Part 2 of the Ongoing Phase 1a Clinical Study of HER-096
Herantis Pharma Oyj Announces First Healthy Volunteer Dosed in the Phase 1a Clinical Study for the Parkinson's Disease Drug Candidate, HER-096
Herantis Pharma plc Announces Approval of Clinical Trial Application for A Phase 1 Study for HER-096
Herantis Pharma Oyj Announces Submission of A Clinical Trial Application for A Phase 1 Study for HER-096
Herantis Pharma plc Announces Appointments to Shareholders' Nomination Committee
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2022
Herantis Pharma plc Announces Executive Changes
Herantis Pharma Oyj Announces Successful HER-096 Initial Results with Blood-Brain Barrier Penetration in Dogs
Herantis Pharma Plc Announces Successful HER-096 Initial Results with Nanoform Technology
Herantis Pharma Oyj Auditor Raises 'Going Concern' Doubt
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2021
Herantis Pharma Oyj Announces CEO Changes
Herantis to Focus on HER-096
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2021
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTIS Stock
  4. News Herantis Pharma Oyj
  5. Other languages